Enveric Biosciences, Inc. (ENVB) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Naples, FL, United States. The current CEO is Joseph Edward Tucker.
ENVB has IPO date of 2015-05-04, 5 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $1.16M.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
